GSK3B and leukemia: Taken together, our findings provided a novel mechanistic therapeutic approach and demonstrated that miR-1246 affected cancer chemo-resistant ability in leukemia cells by directly targeting AXIN2 and GSK-3β and indirectly influencing the activity of Wnt/β-catenin pathway which could mediate the P-gp expression regulation.